CAMB.BR Campine NV Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
08:28
May 25
May 25
Campine long: recycler with tin offset to antimony substitution
Author argues Campine NV is a small, underfollowed European recycler with unusually strong exposure to antimony, tin and battery recycling, and that tin recovery could partially offset the risk that lead-acid battery makers reduce antimony content. Catalysts cited include stricter EU recycling rules, the bolt-on Ecobat French battery recycling acquisition done without issuing shares, and a possible further acquisition in 2026 or 2027. Main stated risks are that 2025 earnings may be peak-cycle on antimony prices, antimony prices could normalize, customers may substitute away, lead prices are weak, recycling environmental liabilities, small-cap liquidity and volatile commodity spreads.
HIGH
13:59
Feb 12
Feb 12
Campine's lead recycling scale-up offsets antimony normalization, driving re-rating
The author argues Campine NV has transformed from an antimony cyclical into a diversified lead-recycling and specialty-alloy business after the 2025 Ecobat acquisition doubled lead capacity to 150,000 t/y. The lead-anode mix (15-18% EBITDA margin vs <7% for standard ingots) and projected 2026 revenue of €480-510M are expected to stabilize earnings despite antimony prices normalizing toward $12,000-13,500/t. Catalysts include 2026 earnings normalization, net-debt-zero by end-2026, and potential ESG-fund inflows tied to the EU Critical Raw Materials Act. The main stated risk is antimony price normalization crushing the old Campine, though the author believes the new lead scale-up offsets it.
HIGH
About CAMB.BR Investor Commentary
Across the available history and selected sources, Buzzberg tracks CAMB.BR (Campine NV) across 1 sources: 2 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: u/Healthy-Matter-4218.